Latest asthma Stories
Microneedle Patches and Subcutaneous Implants Offer Significant Revenue Potential, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
MONROVIA, Calif., Aug. 5, 2014 /PRNewswire/ -- Xencor, Inc.
For U.S. Media Only RIDGEFIELD, Conn., Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
If you’re allergic to dust mites (and chances are you are), help may be on the way. Researchers at the University of Iowa have developed a vaccine that can combat dust-mite allergies by naturally switching the body’s immune response.
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
MONROVIA, Calif., July 24, 2014 /PRNewswire/ -- Xencor, Inc.
MONROVIA, Calif., July 15, 2014 /PRNewswire/ -- Xencor, Inc.
VIENNA, Va., July 10, 2014 /PRNewswire-USNewswire/ -- Allergy & Asthma Network, a leading nonprofit patient education organization, invites you to join its "2014 Venom Allergy 101"
Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...
- totally perplexed and mixed up.
More Images (2 images) »